TheStreet Says BioSante Overvalued
Posted on February 07, 2012 at 13:05 PM EST

TheStreet listed BioSante Pharmaceuticals Inc. (Nasdaq: BPAX) as one of six overvalued biotech stocks saying that it does not have any viable products in its pipeline sending the stock price tumbling 15 cents to $0.90.


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Mortgage Rates, CD Rates & Home Equity Rates provided by Banks.com
Press Release Service provided by PRConnect.
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here